Agenda available for TVT 2016

June 07, 2016


TVT 2016 is a three-day course featuring the latest research and state-of-the-art techniques for transcatheter aortic and mitral valve therapies. This year's conference will emphasize advanced imaging, bioskill demonstrations, and live case transmissions featuring the world's leading experts. The agenda is now available online at:

Sessions showcasing the latest research will focus on updates and new insights from transcatheter valve trials and registries in lower surgical risk patients. Among the trials that will be discussed are:

The meeting will also examine:


Valvular heart disease affects a large number of people who require diagnostic procedures and long-term management. Many patients have no symptoms, but for others, if not treated, advanced heart valve disease can lead to heart failure, stroke, blood clots, or death due to sudden cardiac arrest. Traditionally, valvular heart disease has been treated with surgical repair or replacement. Over the last several years, there have been important advances in concepts, tools, techniques, and patient selection using nonsurgical procedures. Transcatheter valve intervention offers the potential to reduce the procedural morbidity, mortality, and costs of surgical valve replacement or repair while accelerating patient recovery.


June 16-18, 2016


Sheraton Grand Chicago
301 East North Water Street
Chicago, Illinois


The course directors for TVT 2016 are:

Martin B. Leon, MD
NewYork-Presbyterian Hospital/Columbia University Medical Center

Francesco Maisano, MD
UniversitätsSpital Zürich

Nicolo Piazza, MD, PhD
McGill University Health Center

Mark Reisman, MD
University of Washington Medical Center/Regional Heart Center

Gregg W. Stone, MD
New York-Presbyterian Hospital/Columbia University Medical Center

John G. Webb, MD
St. Paul's Hospital


Media may apply for registration by emailing

Can't attend in person? Reporters are eligible for access to Virtual TVT which provides live and on-demand viewing of the meeting sessions.
About CRF

The Cardiovascular Research Foundation (CRF) is a nonprofit research and educational organization dedicated to helping doctors improve survival and quality of life for people suffering from heart and vascular disease. For over 25 years, CRF has helped pioneer innovations in interventional cardiology and has educated doctors on the latest treatments for heart disease. For more information, visit

Cardiovascular Research Foundation

Related Valvular Heart Disease Articles from Brightsurf:

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Is elevated systolic blood pressure associated with risk for valvular heart disease?
A group of 329,237 men and women of white Bristish ancestry with genetic data in the UK Biobank and blood pressure measurements were included in a study that examined the association between systolic blood pressure and risk of major valvular heart disease.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

Impaired cellular force transmission a cause for valvular heart disease
About three per cent of the world's population is affected by valvular heart diseases.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Read More: Valvular Heart Disease News and Valvular Heart Disease Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to